| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 174,152 | $2.89 | $503,958.26 | +7.5% | -31.2% | -31.2% | |
| Dec 12, 2022 | AMRX Amneal Pharmaceuticals, Inc. | Tpg GP A, LLC77 | Former 10% Owner | Sell | 3,884,600 | $2.34 | $9,095,402.44 | -24.0% | -39.8% | +90.2% | |
| Dec 12, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $279.97 | $4,479,460.65 | -34.7% | -19.7% | -10.1% | |
| Dec 9, 2022 | TXMD Therapeuticsmd, Inc. | Rubric Capital Management LP | 10% Owner | Buy | 14,825 | $6.09 | $90,284.25 | +0.9% | -32.1% | -67.6% | |
| Dec 9, 2022 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 9,139 | $4.40 | $40,249.07 | -17.9% | - | - | |
| Dec 9, 2022 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 1,010 | $282.00 | $284,820.00 | -11.7% | -19.7% | -13.8% | |
| Dec 9, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 291,400 | $2.87 | $837,623.22 | +16.0% | -31.2% | -26.3% | |
| Dec 9, 2022 | TXMD Therapeuticsmd, Inc. | Bernick Brian | Co-chief Executive Officer | Sell | 1,255 | $5.28 | $6,621.47 | -13.5% | -32.1% | -67.6% | |
| Dec 8, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $277.21 | $4,435,426.29 | -31.6% | -20.5% | -13.7% | |
| Dec 8, 2022 | TXMD Therapeuticsmd, Inc. | Rubric Capital Management LP | 10% Owner | Buy | 20,413 | $5.66 | $115,638.86 | +0.6% | -21.9% | -65.2% | |
| Dec 7, 2022 | TXMD Therapeuticsmd, Inc. | Naughton Gail K | Director | Sell | 3,922 | $5.26 | $20,635.21 | -100% | -24.3% | -63.2% | |
| Dec 7, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 156,000 | $2.96 | $461,267.80 | +11.3% | -28.7% | -28.0% | |
| Dec 6, 2022 | TXMD Therapeuticsmd, Inc. | Glickman Mark A | Co-chief Executive Officer | Sell | 440 | $4.92 | $2,165.46 | -25.4% | -12.0% | -58.4% | |
| Dec 6, 2022 | PBH Prestige Consumer Healthcare Inc. | P'pool William54 | SVP, GC &Corp Secretary | Sell | 14,780 | $60.76 | $898,032.80 | -41.9% | -2.9% | -2.8% | |
| Dec 6, 2022 | TXMD Therapeuticsmd, Inc. | Walker Marlan D81 | General Counsel | Sell | 1,048 | $4.95 | $5,184.98 | -13.6% | -12.0% | -58.4% | |
| Dec 6, 2022 | DVAX Dynavax Technologies Corp | Hack Andrew A. F.62 | Director | Sell | 1,500,000 | $11.60 | $17,400,000.00 | -27.7% | -11.7% | +15.4% | |
| Dec 6, 2022 | TXMD Therapeuticsmd, Inc. | Donegan Michael C85 | Interim Cfo/ Cao/ VP Of Finance | Sell | 910 | $4.78 | $4,345.25 | -16.7% | -12.0% | -58.4% | |
| Dec 6, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $272.96 | $4,367,312.26 | -22.0% | -10.3% | -13.2% | |
| Dec 5, 2022 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | Director, 10% Owner | Buy | 54,000 | $0.05 | $2,585.00 | - | - | - | |
| Dec 2, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 49,089 | $372.88 | $18,304,192.32 | - | -15.9% | +55.8% | |
| Dec 2, 2022 | PBH Prestige Consumer Healthcare Inc. | P'pool William54 | SVP, GC &Corp Secretary | Sell | 13,862 | $63.60 | $881,623.20 | -40.3% | -4.6% | -8.3% | |
| Dec 2, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $278.19 | $4,450,977.07 | -27.9% | -12.1% | -13.6% | |
| Dec 2, 2022 | BCRX Biocryst Pharmaceuticals Inc | Stonehouse Jon P80 | President &CEO | Sell | 297,573 | $12.94 | $3,851,917.80 | -14.2% | -30.7% | -51.9% | |
| Dec 2, 2022 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 131,053 | $22.72 | $2,977,400.91 | -18.1% | +18.2% | +11.2% | |
| Dec 1, 2022 | PBH Prestige Consumer Healthcare Inc. | Fritz Mary Beth57 | SVP Quality &Regulatory | Sell | 7,114 | $61.57 | $438,008.98 | -20.8% | -3.6% | -6.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.